drug

Switch

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Veterans Medical Research Foundation
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
NCT00338949Phase 4Completed

KOLs & investigators

1
Jonathan M. Meyer, MDKOL score 8

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Veterans Medical Research Foundation
company
trial
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Insulin Resistance
indication
Insulin Resistance
indication
KOL
Jonathan M. Meyer, MD
KOL score 8
person